Skip to main content

Olivia
Kacsits
Sugarman
,
PhD

Assistant Scientist

Olivia K Sugarman, PhD, MPH, studies how policies can promote access to high-quality health services for historically marginalized people, specifically people who use drugs.

Contact Info

1812 Ashland Ave., Rm 390
Baltimore
Maryland
21205
US        

Research Interests

Substance use, mental health, opioid use disorder, drug supply, HIV/AIDS, Hepatitis C, incarceration and health, health policy, health services research, health equity, program and policy evaluation, Medicaid, social determinants of health, mixed methods research, community partnered research

Experiences & Accomplishments
Education
PhD
LSU Health Sciences Center
2022
MPH
Tulane University School of Public Health and Tropical Medicine
2016
BS
University of Notre Dame
2014
Overview

Olivia K. Sugarman, PhD, MPH is an Assistant Scientist in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Dr. Sugarman is a health policy and services researcher.  She applies mixed methods approaches, health behavior frameworks, and community-partnered research principles to study mental health and HIV and HCV, specifically in people who use drugs and people affected by the criminal-legal system. Dr. Sugarman also serves as lead faculty with the evaluation team on the Bloomberg Overdose Prevention Initiative – a multi-year campaign focused on seven states to implement evidence-based overdose reduction strategies. Dr. Sugarman's most recent projects focus on opportunities to co-treat chronic hepatitis c and opioid use disorder, enhance access to naloxone and opioid use disorder treatment, and policy responses to xylazine as a drug supply adulterant.

Select Publications

Selected publications from the last 5 years

  • Sugarman OK, Shah H, Whaley S, McCourt A, Saloner B, Bandara S. A content analysis of legal policy responses to xylazine in the illicit drug supply in the United States. International Journal of Drug Policy. 2024;129:104472.   doi:10.1016/j.drugpo.2024.104472

  • Sugarman OK, Saloner B, Richards TM, et al. Association of buprenorphine retention and  subsequent adverse outcomes following non-fatal overdose: An analysis using statewide linked Maryland databases. Drug and Alcohol Dependence. 2024;258:111281. doi:10.1016/j.drugalcdep.2024.111281

  • Sugarman OK, Li W, Saloner B. Medications For Opioid Use Disorder Increased Among  Louisiana Medicaid Enrollees During Policy Reforms, 2018–21. Health Affairs.   2024;43(1):46-54. doi:10.1377/hlthaff.2023.00715

  • Sugarman OK, Hulsey EG, Heller D. Achieving the Potential of Naloxone Saturation by  Measuring Distribution. JAMA Health Forum. 2023;4(10):e233338.           doi:10.1001/jamahealthforum.2023.3338

  • Sugarman OK, Wendell DA, Wennerstrom AB, Bachhuber MA, Robinson WT. Examining  Pre-Release Interventions on HIV Outcomes 12 Months After Release from Louisiana State Corrections. AIDS and Behavior. Published online June 12, 2023. doi:10.1007/s10461-023-04106-z